Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
about
Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.Increased HAGLR expression promotes non-small cell lung cancer proliferation and invasion via enhanced de novo lipogenesis.SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers.STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4.A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a.Role of Non-Coding RNAs in the Etiology of Bladder Cancer.BANCR: a novel oncogenic long non-coding RNA in human cancers.LncRNA HOXD-AS1 promotes melanoma cell proliferation and invasion by suppressing RUNX3 expression.Long Non Coding RNA Expression Intersecting Cancer and Spermatogenesis: A Systematic ReviewAFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers.Comprehensive analysis of long noncoding RNA-mRNA co-expression patterns in thyroid cancer.Tetracycline-controllable artificial microRNA-HOTAIR + EZH2 suppressed the progression of bladder cancer cells.HOXD-AS1 promotes cell proliferation, migration and invasion through miR-608/FZD4 axis in ovarian cancer.The Function and Mechanism of Long Non-coding RNA-ATB in Cancers.lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.Long non-coding RNA HOXD-AS1 promotes tumor progression and predicts poor prognosis in colorectal cancer.Long noncoding RNA HOXD-AS1 in various cancers: a meta-analysis and TCGA data review
P2860
Q38704737-8CCFAC04-8264-4137-BFDB-4F61907358DCQ38706056-DAF59595-62F0-402A-B6DD-AEFECA83F743Q39398940-53A18332-8EB0-4D0A-9E5B-2A232B890D47Q41431023-E2219084-665F-42DA-A7C5-72E4A56E69BEQ42128391-DC6370A4-A208-433C-BC94-28EF0AA78BDBQ42370600-86CD2672-5D6D-430C-99A8-AA7F3F3EF1E6Q46236214-1C55FF82-B9DF-4A01-8413-1F29EAECEF66Q47141107-4AE1504A-CF3A-4E49-AE91-EEADC6ABB47BQ47193400-01D0BE18-75C9-4004-96B3-27DE248C5754Q47601811-B4CAD0A3-C7BD-4875-9D9B-9E870769B021Q47618652-9EE6A88D-F00A-4471-AA27-723B0985B10BQ47941020-D5F32365-D333-4FAE-870A-C7525EAD4604Q48186262-35447B4F-EACC-4FE0-AEE9-BE03A4B70929Q49459657-233481CA-D7A5-45E7-B30A-C717D37F8D2AQ52564659-49E10438-CB2A-4BF8-AC7F-60E57F92C5A6Q52771926-7CFED560-F172-463D-B8FC-B836FF3DD2C9Q55006226-C74B95E4-86D1-4312-AF51-34C4E4CBFA1AQ59135056-74019343-C791-434A-8601-600757A2A090
P2860
Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synthetic tetracycline-control ...... progression of bladder cancer.
@en
Synthetic tetracycline-control ...... progression of bladder cancer.
@nl
type
label
Synthetic tetracycline-control ...... progression of bladder cancer.
@en
Synthetic tetracycline-control ...... progression of bladder cancer.
@nl
prefLabel
Synthetic tetracycline-control ...... progression of bladder cancer.
@en
Synthetic tetracycline-control ...... progression of bladder cancer.
@nl
P2093
P2860
P1476
Synthetic tetracycline-control ...... progression of bladder cancer.
@en
P2093
Chengle Zhuang
Guoping Zhao
Junhao Lin
Mingwei Chen
Weiren Huang
P2860
P2888
P356
10.1186/S13046-016-0372-5
P577
2016-06-21T00:00:00Z
P6179
1000009617